PD-L1 is a double-edged sword in colorectal cancer: the prognostic value of PD-L1 depends on the cell type expressing PD-L1

被引：0
|
作者：
Hsiang-Ling Ho
Teh-Ying Chou
Shung-Haur Yang
Jeng-Kai Jiang
Wei-Shone Chen
Yee Chao
Hao-Wei Teng
机构：
[1] Taipei Veterans General Hospital,Division of Molecular Pathology, Department of Pathology and Laboratory Medicine
[2] National Yang-Ming University,Department of Biotechnology and Laboratory Science in Medicine
[3] National Yang-Ming University,Institute of Clinical Medicine
[4] Taipei Veterans General Hospital,Division of Medical Oncology, Department of Oncology
[5] National Yang-Ming University,School of Medicine
[6] Taipei Veterans General Hospital,Division of Colon and Rectum Surgery, Department of Surgery
[7] National Yang-Ming University Hospital,Department of Surgery
来源：
Journal of Cancer Research and Clinical Oncology | 2019年 / 145卷
关键词：
Colorectal cancer; Microsatellite instability; PD-L1; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1785 / 1794
页数：9
相关论文
共 50 条
  • [31] Impact of PD-L1 feedback modulation on the sensitivity of anti-PD-1/PD-L1
    Zhu, Jian
    Zhu, Rebecca L.
    CANCER RESEARCH, 2019, 79 (13)
  • [32] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
    Lin, Heng
    Wei, Shuang
    Vatan, Linda
    Kryczek, Ilona
    Zou, Weiping
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [33] Comparison of PD-L1 Immunohistochemistry Assays and Response to PD-L1 Inhibitors
    Dacic, S.
    Ancevski, K.
    Aberrbock, S.
    Herbst, C.
    Villaruz, L.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2115 - S2115
  • [34] Relevance of host and tumor PD-L1 in PD-L1 pathway blockade
    Kryczek, Ilona
    Lin, Heng
    Wei, Shuang
    Green, Michael
    Zou, Weiping
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [35] Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer
    Niu, Mengke
    Liu, Yiming
    Yi, Ming
    Jiao, Dechao
    Wu, Kongming
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [36] PD-L1 methylation restricts PD-L1/PD-1 interactions to control cancer immune surveillance
    Huang, Changsheng
    Ren, Shengxiang
    Chen, Yaqi
    Liu, Anyi
    Wu, Qi
    Jiang, Tao
    Lv, Panjing
    Song, Da
    Hu, Fuqing
    Lan, Jingqing
    Sun, Li
    Zheng, Xue
    Luo, Xuelai
    Chu, Qian
    Jia, Keyi
    Li, Yan
    Wang, Jun
    Zou, Caicun
    Hu, Junbo
    Wang, Guihua
    SCIENCE ADVANCES, 2023, 9 (21)
  • [37] Soluble PD-L1 levels correlate with efficacy of PD-1/PD-L1 inhibitors in lung cancer
    Kang, Da Hyun
    Koh, Jeong Suk
    Chung, Chaeuk
    Park, Dongil
    Lee, Song-I
    Lee, Jeong Eun
    RESPIROLOGY, 2023, 28 : 99 - 99
  • [38] PD-L1/PD-L1 signalling promotes colorectal cancer cell migration ability through RAS/MEK/ERK
    Cao, Yihui
    Liang, Weiye
    Fang, Lian
    Liu, Ming-kai
    Zuo, Jia
    Peng, Ying-long
    Shan, Jia-jie
    Sun, Rui-xia
    Zhao, Jie
    Wang, Jian
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2022, 49 (12) : 1281 - 1293
  • [39] PD-1/PD-L1 as a prognostic factor in leukemia
    Hadi Rezaeeyan
    Seyedeh Nafiseh Hassani
    Mojgan Barati
    Mohammad Shahjahani
    Najmaldin Saki
    Journal of Hematopathology, 2017, 10 : 17 - 24
  • [40] The clinical significance of PD-L1 in colorectal cancer
    Ntomi, Vasileia
    Foukas, Periklis
    Papaconstantinou, Dimitrios
    Antonopoulou, Ioanna
    Pikoulis, Andreas
    Panagiotides, Ioannis
    Pikoulis, Emmanouil
    Syrigos, Konstantinos
    ONCOLOGY REPORTS, 2021, 45 (06)
12345